GlassScriptPhysician profile
Rabiul Ryan
NPI 1841782844
$4,198.29
in general payments reported to CMS, 2019-2025
10 companies · $1,989 in 2025
The $1,989 reported for 2025 was more than what 82% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,210 · 2025: $1,989.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,424 · Education: $1,016 · Food and Beverage: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,423.53 |
| Education | $1,016.15 |
| Food and Beverage | $758.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,908.85 | 2023 | Senza |
| Curonix LLC | $1,560.51 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $241.19 | 2025 | Spinejack, Optablate |
| Globus Medical, INC. | $155.44 | 2025 | Senza |
| Boston Scientific Corporation | $138.33 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $85.70 | 2025 | Proclaim |
| Averitas Pharma INC. | $38.06 | 2025 | Qutenza |
| Saluda Medical Americas, INC. | $24.19 | 2025 | Evoke |
| Biotronik Nro, INC. | $23.46 | 2025 | Prospera |
| Spinal Simplicity, LLC | $22.56 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rabiul Ryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.